Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06350825Phase 3Recruiting
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Metastatic Prostate CancerTherapy, Directly Observed
PrincipalinvestigatorStart date: 2016-01-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The First Affiliated Hospital with Nanjing Medical University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

María J Méndez, MD

COMPLEJO HOSPITALARIO REGIONAL REINA SOFÍA, Servicio de Oncología Médica

Related
1 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Daniel Kwon, MD

University of California, San Francisco

Related
6 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Neeta Pandit-Taskar, MD

Memorial Sloan Kettering Cancer Center

Related
8 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Francesco Perrone, M.D., Ph.D

National Cancer Institute Naples, Italy; Director Clinical Trials Unit

Related
9 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Pablo Maroto, MD

HOSPITAL DE LA SANTA CREU I SANT PAU, Servicio de Oncología Médica

Related
1 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

William D Figg, Pharm.D.

National Cancer Institute (NCI)

Related
11 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Begoña Perez-Valderrama, MD

COMPLEJO HOSPITALARIO REGIONAL VIRGEN DEL ROCIO, Servicio de Oncología Médica

Related
1 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Daniel E Castellano, MD

HOSPITAL UNIVERSITARIO 12 DE OCTUBRE,Servicio de Oncología Médica

Related
1 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Carmen Santander, MD

HOSPITAL UNIVERSITARIO MIGUEL SERVET, Servicio de Oncología Médica

Related
1 trials

Shared therapeutic areas:

Metastatic Prostate Cancer
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06350825Phase 3PrincipalInvestigator

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Metastatic Prostate CancerTherapy, Directly Observed
Recruiting

All 1 trials loaded